Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Intangibles (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Intangibles for 16 consecutive years, with $153.4 million as the latest value for Q4 2025.

  • Quarterly Intangibles fell 41.54% to $153.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $153.4 million through Dec 2025, down 41.54% year-over-year, with the annual reading at $153.4 million for FY2025, 41.54% down from the prior year.
  • Intangibles for Q4 2025 was $153.4 million at Myriad Genetics, down from $163.1 million in the prior quarter.
  • The five-year high for Intangibles was $559.9 million in Q1 2021, with the low at $153.4 million in Q4 2025.
  • Average Intangibles over 5 years is $337.3 million, with a median of $357.7 million recorded in 2023.
  • The sharpest move saw Intangibles dropped 3.83% in 2023, then tumbled 47.81% in 2025.
  • Over 5 years, Intangibles stood at $404.1 million in 2021, then decreased by 6.04% to $379.7 million in 2022, then dropped by 7.95% to $349.5 million in 2023, then decreased by 24.92% to $262.4 million in 2024, then crashed by 41.54% to $153.4 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $153.4 million, $163.1 million, and $170.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.